SUBSCRIBE
SUBSCRIBE

Organogenesis Inc

NEWS
Business
Organogenesis Inc. Partners with National Tissue Engineering Center
December 11, 2007
 · 
1 min read
IN THE PRESS
Business
Organogenesis Holdings Inc. Reports Second Quarter 2023 Financial Results; Withdraws Fiscal Year 2023 Guidance
August 9, 2023
 · 
17 min read
Business
Organogenesis Holdings Inc. to Report Second Quarter of Fiscal Year 2023 Financial Results on August 9, 2023
July 10, 2023
 · 
1 min read
Business
Organogenesis Holdings Inc. Reports First Quarter 2023 Financial Results
May 10, 2023
 · 
16 min read
Business
Organogenesis President and Chief Executive Officer Gary S. Gillheeney, Sr. Elected Chair of the Board of DirectorsArthur S. Leibowitz to Serve as Lead Independent Director
April 27, 2023
 · 
5 min read
Business
Organogenesis Holdings Inc. to Report First Quarter of Fiscal Year 2023 Financial Results on May 10, 2023
April 10, 2023
 · 
1 min read
Business
Organogenesis Holdings Inc. Reports Fourth Quarter 2022 and Fiscal Year 2022 Financial Results; Introduces Fiscal Year 2023 Guidance
March 1, 2023
 · 
23 min read
Drug Development
Organogenesis Reports Positive Interim Analysis of Phase 3 Clinical Trial of ReNu for Knee Osteoarthritis
March 1, 2023
 · 
4 min read
Business
Organogenesis Holdings Inc. to Report Fourth Quarter and Fiscal Year 2022 Financial Results on March 1, 2023
February 9, 2023
 · 
1 min read
Genetown
Organogenesis Holdings Inc. to Participate in the Cantor Fitzgerald Medical and Aesthetic Dermatology, Ophthalmology and Medtech Conference
December 5, 2022
 · 
1 min read
Business
Organogenesis Holdings Inc. to Report Third Quarter of Fiscal Year 2022 Financial Results on November 9, 2022
September 26, 2022
 · 
1 min read
Load More
JOBS